JS Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
JS Capital Management's WST Position: Q2 2021 in Review
JS Capital Management sold out of West Pharmaceutical (WST) in Q2 2021, closing a stake of 3,100 shares — an estimated $874K sold.
JS Capital Management first reported a position in WST in Q1 2021 and held it in 1 quarter. The position peaked at $874K in Q1 2021. 640 funds tracked by Wall St. Rank hold WST as of Q2 2021.
- JS Capital Management reported no remaining West Pharmaceutical position as of Q2 2021 after selling out during the quarter.
- JS Capital Management sold 3,100 West Pharmaceutical shares in Q2 2021, an estimated $874K.
- JS Capital Management first reported a position in West Pharmaceutical in Q1 2021 and held it in 1 quarter.
- JS Capital Management's West Pharmaceutical position peaked at $874K in Q1 2021.
- 640 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2021.
Based on JS Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.